Suppr超能文献

肝脏与肠道之间的遥感:微生物代谢产物的重要性。

Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.

作者信息

Fu Zidong Donna, Cui Julia Yue

机构信息

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle WA 98105.

出版信息

Curr Pharmacol Rep. 2017 Jun;3(3):101-113. doi: 10.1007/s40495-017-0087-0. Epub 2017 Mar 3.

Abstract

UNLABELLED

Recent technological advancements including metagenomics sequencing and metabolomics have allowed the discovery of critical functions of gut microbiota in obesity, malnutrition, neurological disorders, asthma, and xenobiotic metabolism. Classification of the human gut microbiome into distinct "enterotypes" has been proposed to serve as a new paradigm for understanding the interplay between microbial variation and human disease phenotypes, as many organs are affected by gut microbiota modifications during the pathogenesis of diseases. Gut microbiota remotely interacts with liver and other metabolic organs of the host through various microbial metabolites that are absorbed into the systemic circulation.

PURPOSE OF REVIEW

The present review summarizes recent literature regarding the importance of gut microbiota in modulating the physiological and pathological responses of various host organs, and describes the functions of the known microbial metabolites that are involved in this remote sensing process, with a primary focus on the gut microbiota-liver axis.

RECENT FINDINGS

Under physiological conditions, gut microbiota modulates the hepatic transcriptome, proteome, and metabolome, most notably down-regulating cytochrome P450 3a mediated xenobiotic metabolism. Gut microbiome also modulates the rhythmicity in liver gene expression, likely through microbial metabolites, such as butyrate and propionate that serve as epigenetic modifiers. Additionally, the production of host hormones such as primary bile acids and glucagon like peptide 1 is altered by gut microbiota to modify intermediary metabolism of the host.

SUMMARY

Dysregulation of gut microbiota is implicated in various liver diseases such as alcoholic liver disease, non-alcoholic steatohepatitis, liver cirrhosis, cholangitis, and liver cancer. Gut microbiota modifiers such as probiotics and prebiotics are increasingly recognized as novel therapeutic modalities for liver and other types of human diseases.

摘要

未标注

包括宏基因组测序和代谢组学在内的近期技术进步,已使人们发现肠道微生物群在肥胖、营养不良、神经疾病、哮喘和外源性物质代谢中的关键作用。有人提出将人类肠道微生物群分类为不同的“肠型”,作为理解微生物变异与人类疾病表型之间相互作用的新范例,因为在疾病发病过程中,许多器官会受到肠道微生物群改变的影响。肠道微生物群通过各种被吸收进入体循环的微生物代谢产物,与宿主的肝脏和其他代谢器官进行远程相互作用。

综述目的

本综述总结了近期有关肠道微生物群在调节宿主各器官生理和病理反应中的重要性的文献,并描述了参与这一遥感过程的已知微生物代谢产物的功能,主要关注肠道微生物群-肝脏轴。

最新发现

在生理条件下,肠道微生物群可调节肝脏转录组、蛋白质组和代谢组,最显著的是下调细胞色素P450 3a介导的外源性物质代谢。肠道微生物群还可能通过微生物代谢产物(如作为表观遗传修饰剂的丁酸和丙酸)调节肝脏基因表达的节律性。此外,肠道微生物群会改变宿主激素(如初级胆汁酸和胰高血糖素样肽1)的产生,从而改变宿主的中间代谢。

总结

肠道微生物群失调与多种肝脏疾病有关,如酒精性肝病、非酒精性脂肪性肝炎、肝硬化、胆管炎和肝癌。益生菌和益生元等肠道微生物群调节剂越来越被认为是治疗肝脏及其他类型人类疾病的新型治疗手段。

相似文献

1
Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites.
Curr Pharmacol Rep. 2017 Jun;3(3):101-113. doi: 10.1007/s40495-017-0087-0. Epub 2017 Mar 3.
2
Gut microbiota and host metabolism in liver cirrhosis.
World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597.
3
Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.
Proc Nutr Soc. 2019 Aug;78(3):319-328. doi: 10.1017/S0029665118002756. Epub 2019 Jan 10.
5
Gut-microbiota derived bioactive metabolites and their functions in host physiology.
Biotechnol Genet Eng Rev. 2021 Oct;37(2):105-153. doi: 10.1080/02648725.2021.1989847. Epub 2021 Oct 22.
6
Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota.
Front Med. 2018 Dec;12(6):645-657. doi: 10.1007/s11684-018-0645-9. Epub 2018 Sep 4.
7
Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota.
Cancer Sci. 2021 Nov;112(11):4433-4443. doi: 10.1111/cas.15142. Epub 2021 Sep 27.
8
The impact of metabolites derived from the gut microbiota on immune regulation and diseases.
Int Immunol. 2020 Sep 30;32(10):629-636. doi: 10.1093/intimm/dxaa041.
9
Microbiome is a functional modifier of P450 drug metabolism.
Curr Pharmacol Rep. 2019 Dec;5(6):481-490. doi: 10.1007/s40495-019-00200-w. Epub 2019 Oct 19.

引用本文的文献

4
Influences of Oral Administration of Probiotics on Posthepatectomy Recovery in Patients in Child-Pugh Grade.
Comput Math Methods Med. 2022 Jul 8;2022:2942982. doi: 10.1155/2022/2942982. eCollection 2022.
6
Alterations in Faecal Metagenomics and Serum Metabolomics Indicate Management Strategies for Patients With Budd-Chiari Syndrome.
Front Cell Infect Microbiol. 2021 Oct 21;11:730091. doi: 10.3389/fcimb.2021.730091. eCollection 2021.
7
Methionine Deficiency Affects Liver and Kidney Health, Oxidative Stress, and Ileum Mucosal Immunity in Broilers.
Front Vet Sci. 2021 Sep 22;8:722567. doi: 10.3389/fvets.2021.722567. eCollection 2021.
8
Interaction Between the Intestinal Microbial Community and Transcriptome Profile in Common Carp ( L.).
Front Microbiol. 2021 May 28;12:659602. doi: 10.3389/fmicb.2021.659602. eCollection 2021.

本文引用的文献

2
Ticking in Place for the Microbiome to Message Out.
Cell Metab. 2016 Dec 13;24(6):775-777. doi: 10.1016/j.cmet.2016.11.015.
3
Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury.
J Am Soc Nephrol. 2017 May;28(5):1450-1461. doi: 10.1681/ASN.2016030255. Epub 2016 Dec 7.
4
Nutrition and chronic inflammatory rheumatic disease.
Joint Bone Spine. 2017 Oct;84(5):547-552. doi: 10.1016/j.jbspin.2016.10.003. Epub 2016 Nov 30.
5
Microbiota Diurnal Rhythmicity Programs Host Transcriptome Oscillations.
Cell. 2016 Dec 1;167(6):1495-1510.e12. doi: 10.1016/j.cell.2016.11.003.
6
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
J Hepatol. 2017 Apr;66(4):806-815. doi: 10.1016/j.jhep.2016.11.008. Epub 2016 Nov 25.
8
Gut microbiota induce IGF-1 and promote bone formation and growth.
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7554-E7563. doi: 10.1073/pnas.1607235113. Epub 2016 Nov 7.
9
Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.
Clin Gastroenterol Hepatol. 2017 Apr;15(4):600-602. doi: 10.1016/j.cgh.2016.10.029. Epub 2016 Nov 2.
10
Gut microbiome and liver diseases.
Gut. 2016 Dec;65(12):2035-2044. doi: 10.1136/gutjnl-2016-312729. Epub 2016 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验